
Grandem 1mg Tablet
Marketer
Aristo Pharmaceuticals Pvt Ltd
Salt Composition
Granisetron (1mg)
Overview Grandem 1mg Tablet
Ondansetron 1mg tablets are prescribed to alleviate nausea and vomiting resulting from surgery, chemotherapy, or radiation therapy. This medication is not effective against other cancer treatment side effects, nor is it particularly useful for motion sickness-related vomiting. Always adhere to your physician's prescribed dosage and schedule; consistent timing is recommended. Discontinuing this medication abruptly is discouraged; consult your doctor first. If vomiting occurs within an hour of taking a dose, repeat the dose and avoid large meals for the remainder of the day. Common side effects include headache, constipation, diarrhea, and fatigue. Dizziness and drowsiness are also possible; avoid driving or activities requiring concentration until you understand the medication's effects on you. These effects generally subside upon cessation of treatment; however, persistent or bothersome symptoms warrant consultation with your doctor for management strategies. Prior to commencing treatment, inform your physician of any pre-existing heart or liver conditions, or bowel obstructions. Similarly, disclose all other medications, particularly those for epilepsy, heart conditions, cancer, or depression, as interactions are possible. Pregnant or breastfeeding individuals should consult their healthcare provider for guidance.
Uses of Grandem 1mg Tablet
Chemotherapy-induced emesis
Major Benefits of Grandem 1mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Grandem 1mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Grandem 1mg Tablet:
- Weakness
- Headache
- Constipation
- Diarrhea
- Insomnia (difficulty in sleeping)
How to use Grandem 1mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the 1mg Grandem tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
How Grandem 1mg Tablet works:
Grandem 1mg tablets counter nausea and vomiting. This antiemetic medication achieves this by inhibiting serotonin, a neurotransmitter in the brain that can trigger these symptoms following surgery or cancer therapy (chemotherapy).
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Grandem 1mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The use of Grandem 1mg tablets during pregnancy is typically deemed safe. Preclinical trials using animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Using Grandem 1mg tablets while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Grandem 1mg Tablets.
KidneySAFE IF PRESCRIBED
The use of Grandem 1mg Tablet in patients with kidney disease is likely safe. Preliminary evidence indicates dose modification may be unnecessary. However, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Grandem 1mg tablets are likely safe for individuals with hepatic impairment. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Grandem 1mg Tablet :
Should you forget a Grandem 1mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Grandem 1mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Indazole-based compound |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | 5-HT3 receptor blockers |
